Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Genesis (United States) is Scopus-indexed (Q2, CiteScore 4.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Liss Inc..
Checked against the index lists dated .
ISSN 1526-954XVerify ISSN ↗1526-968XVerify ISSN ↗
Publisher: Wiley-Liss Inc.
Cost to publish: About US$3,800 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 170 / 357 | 52nd | Q2 |
| Endocrinology | 74 / 132 | 44th | Q3 |
| Cell Biology | 189 / 289 | 34th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q2, CiteScore 4.7.
Genesis (United States) is Q2 in Genetics (rank 170 of 357), Q3 in Endocrinology (rank 74 of 132) and Q3 in Cell Biology (rank 189 of 289), by CiteScore 2025.
Genesis (United States) is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q2 at the 52nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.870, quartile Q2, with an H-index of 128.
The publisher lists an article processing charge of about US$3,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Genesis (United States) is published by Wiley-Liss Inc. Its print ISSN is 1526-954X and its online ISSN is 1526-968X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Genesis (United States) has an h-index of 136 and a 2-year mean of 1.42 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q2. On 2-year citations it ranks #267 of 353 Scopus journals in Genetics.
Genesis (United States) published 43 papers in 2025; its busiest recent year was 2017 with 107. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from United States (38.5%), China (20.2%) and Japan (12.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.